Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06347445
Status:
COMPLETED
Last Update Posted:
2024-04-04
First Post:
2024-03-29
Brief Title:
Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 TEMD-2 Study
Sponsor:
Gulhane School of Medicine
Organization:
Gulhane School of Medicine
Study Overview
Official Title:
Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 TEMD-2 Study
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TEMD-2
Brief Summary:
This study evaluates the metabolic control status cardiovascular risk and frequency of comorbidities in diabetic patients followed in tertiary treatment centers in Turkey
Detailed Description:
Diabetes mellitus is one of the most common chronic diseases worldwideThe prevalence of diabetes is increased significantly in Türkiye from 72 in 2002 to 137 in 2012 This increasing prevalence leads to serious public health problems and a significant economic burden Many important diseases such as hypertension and dyslipidemia accompany the picture in diabetic patients The optimal treatment of diabetes and prevention of diabetic complications especially the cardiovascular outcomes is utmost important Although achieving glycemic targets in patients with diabetes is of great importance blood glucose is not the only predictor of cardiovascular outcome in diabetes Optimization of other metabolic parameters such as lipids arterial blood pressure ABP and body weight as well as a healthy lifestyle are utmost important
Common problems in diabetic patients such as sleep disorders and sexual dysfunction affect glycemia regulation in these patientsThere is little data on the frequency of these diseases in diabetic patients in Türkiye
In the TEMD-1 study conducted in 2017 the rates of diabetic patients achieving metabolic goals and the factors affecting these rates were revealed in Turkish patients with diabetes The findings obtained in the current study will be compared with the findings in 2017 and in addition the frequency of comorbidities such as sleep disorder sexual dysfunction and depression will be tried to be revealed
Common problems in diabetic patients such as sleep disorders and sexual dysfunction affect glycemia regulation in these patientsThere is little data on the frequency of these diseases in diabetic patients in Türkiye
In the TEMD-1 study conducted in 2017 the rates of diabetic patients achieving metabolic goals and the factors affecting these rates were revealed in Turkish patients with diabetes The findings obtained in the current study will be compared with the findings in 2017 and in addition the frequency of comorbidities such as sleep disorder sexual dysfunction and depression will be tried to be revealed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None